Related Experiment Video
Updated: Dec 23, 2025
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Case report: A kidney transplant patient with mild COVID-19
Emre Arpali1, Basak Akyollu1, Berna Yelken1
1Department of Organ Transplantation, Koç University Hospital, İstanbul, Turkey.
Insights
The study highlights the unknown course of Coronavirus Disease 2019 (COVID-19) in kidney transplant recipients. It suggests re-evaluating SARS-CoV-2 screening protocols for solid-organ transplant patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Background:
- Coronavirus Disease 2019 (COVID-19) is a global pandemic with varying mortality rates.
- Elderly patients and those with comorbidities face higher risks.
- The clinical course of COVID-19 in immunosuppressed transplant patients remains largely unknown.
Observation:
- This case report details the clinical features of a kidney transplant recipient diagnosed with COVID-19.
- The patient's specific presentation and disease progression are documented.
- Management strategies for this unique patient population were employed.
Findings:
- The study presents the clinical features and treatment approach for a kidney transplant patient with COVID-19.
- It underscores the need for a tailored management strategy in this vulnerable group.
- The case suggests potential atypical presentations in immunosuppressed individuals.
Implications:
- Findings suggest that current screening protocols for SARS-CoV-2 may need re-evaluation for solid-organ transplant recipients.
- A unique and individualized approach to managing COVID-19 in transplant patients is warranted.
- This research contributes to understanding COVID-19's impact on immunocompromised populations.
Abstract:
Coronavirus Disease 2019 (COVID-19) is currently a pandemic with a mortality rate of 1%-6% in the general population. However, the mortality rate seems to be significantly higher in elderly patients, especially those hospitalized with comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations in immunosuppressed patients, the course of the disease in the transplant patient population is unknown. Hence, the management of these patients with COVID-19 is an area of interest, and a unique approach is warranted. Here, we report the clinical features and our treatment approach for a kidney transplant patient with a diagnosis of COVID-19. We believe that screening protocols for SARS-Cov-2 should be re-evaluated in patients with solid-organ transplants.
